ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,319Medicare Part D Prescriptions Filled, Including Refills

Rank: 89 out of 917

$552K Total Retail Price of All Prescriptions

Rank: 88 out of 917

557 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
27% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 557 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

6% of this provider’s 557 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

4% of this provider’s 9,192 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
SIMVASTATIN 587 558 1 2
FUROSEMIDE 439 408 2 7
LEVOTHYROXINE SODIUM 374 334 3 3
POTASSIUM CHLORIDE 373 345 4 16
OMEPRAZOLE 319 251 5 4
METFORMIN HCL 313 290 6 8
LISINOPRIL 306 265 7 1
ENALAPRIL MALEATE 271 257 8 79
AMLODIPINE BESYLATE 261 249 9 5
HYDROCHLOROTHIAZIDE 238 225 10 9
METOPROLOL TARTRATE 229 223 11 11
FLUTICASONE PROPIONATE 209 191 12 26
GABAPENTIN 206 187 13 17
GLYBURIDE 198 170 R 14 71
ATENOLOL 197 187 15 12
CITALOPRAM HBR 183 154 16 15
LOSARTAN POTASSIUM 169 166 17 13
CRESTOR 155 126 18 30
ATORVASTATIN CALCIUM 141 120 19 14
METOPROLOL SUCCINATE 110 98 20 18
LANTUS 110 93 20 37
WARFARIN SODIUM 104 94 22 10
BENAZEPRIL HCL 98 97 23 80
TAMSULOSIN HCL 92 88 24 25
DIGOXIN 90 90 25 41
OXYBUTYNIN CHLORIDE 90 85 25 76
PROAIR HFA 88 82 27 35
PREDNISONE 87 72 28 34
RISPERIDONE 83 53 29 51
DONEPEZIL HCL 81 81 30 32
TRAZODONE HCL 79 62 31 22
DIOVAN 78 78 32 49
SPIRIVA 75 75 33 45
ACTOS 75 72 33 112
ALLOPURINOL 74 71 35 31
SERTRALINE HCL 73 49 36 24
CYCLOBENZAPRINE HCL 72 27 R 37 65
HYDROCODONE-ACETAMINOPHEN 72 54 S3 37 6
ALENDRONATE SODIUM 71 71 39 23
HUMALOG 69 65 40 151
PRAVASTATIN SODIUM 68 68 41 20
PROPRANOLOL HCL 66 55 42 126
SPIRONOLACTONE 62 59 43 55
COLCRYS 61 37 44 255
OXYCODONE-ACETAMINOPHEN 60 49 S2 45 46
CIPROFLOXACIN HCL 60 56 45 72
NATEGLINIDE 60 60 45 363
DILTIAZEM ER 56 48 48 106
NOVOLOG 56 44 48 98
CARVEDILOL 52 48 50 33
DILTIAZEM 24HR CD 51 51 51 95
INSULIN SYRINGE 50 40 52 83
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 7, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.